Lanham O'Dell & Company’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Lanham O'Dell & Company's AMGN Position: Q4 2025 in Review
Lanham O'Dell & Company increased its Amgen (AMGN) stake by 0.13% in Q4 2025, buying an estimated $317 and bringing the position to 745 shares worth $244K. The position accounts for 0.07% of the portfolio, ranked #33.
Lanham O'Dell & Company first reported a position in AMGN in Q2 2024 and has held it in 5 quarters since. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Lanham O'Dell & Company held 745 shares of Amgen worth $244K as of Q4 2025.
- Lanham O'Dell & Company bought 1 Amgen share in Q4 2025, an estimated $317.
- Amgen made up 0.07% of Lanham O'Dell & Company's portfolio in Q4 2025, its #33 holding.
- Lanham O'Dell & Company first reported a position in Amgen in Q2 2024 and has held it in 5 quarters since.
- 3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Lanham O'Dell & Company's 13F filing for Q4 2025, filed 12 Jan 2026.